MARINA KUPERMAN: Open Payments
NPI 1043642887 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 29 payments from 9 companies in 2025. Trend: 2023 $576 · 2024 $172 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 9 | $171 |
| Astellas Pharma US Inc | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| Exeltis, USA Inc. | 3 | $56 |
| Biogen, Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: ACCRUFER, Veozah, XIFAXAN, MYFEMBREE, SLYND, ZURZUVAE, Auvelity, SPRAVATO.
Industry payments across NY — which companies pay providers there.
